Leading the way to safer medication
 Crosscheck  Recommender

Alectinib

Description

Alectinib is a highly selective and potent ALK and RET tyrosine kinase inhibitor. In preclinical studies, inhibition of ALK tyrosine kinase activity led to blockage of downstream signalling pathways including STAT 3 and PI3K/AKT and induction of tumour cell death (apoptosis).

ATC Classification

Code
Title
Category
L01ED03
Alectinib
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01ED Anaplastic lymphoma kinase (ALK) inhibitors

Trade names

Trade name
Countries

Australia Austria Cyprus France Netherlands

Canada

Product Monographs

Monograph
Type
Country
ALECENSA Hard capsule
MPI, EU: SmPC